A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
Clinical trial NCT04987489 · COMPLETED
Trial details
- NCT number
- NCT04987489
- Sponsor
- Forma Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2025-09-03
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.